Jason Silvers, President & CFO at Generate Biomedicines, Inc. (GENB), bought 1,500 shares at $16.00 ($24K) on 2026-03-02, disclosed to the SEC on 2026-03-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.00 | 500 | $8K | 33.3% |
| 2 | $16.00 | 1,000 | $16K | 66.7% |
| Total | $16.00 avg | 1,500 | $24K | 100% |